Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2004

View Archived Issues

Targeting telomerase for multiple myeloma therapy

Phase I pilot trial of L612 HuMAb in metastatic melanoma

Array BioPharma signs for use of CyDex's Captisol

TopoTarget and deCODE collaborate on improved cancer treatments

Series B financing to fund development of BioRexis' biopharmaceuticals

SurroMed and Biogen Idec extend collaborative research agreement

Xenova focuses on highest potential clinical stage programs

Aprepitant enhances the efficacy of standard antiemetics for chemotherapy patients

Aloxi incorporated in NCCN antiemetic guidelines for CINV

Promising candidate for treatment of acute stroke

ChemoCentryx and Forest collaborate on chemokine-based therapeutics

New inhibitors of VEGFR2 and FGFR1 identified by BMS scientists

Argenta describes new HDAC inhibitors and their use in cancer and other disorders

AstraZeneca team prepares and tests new Tie-2 inhibitors

Novel antiinflammatory erythromycins devoid of antibiotic activity claimed by Zambon

Bayer scientists design novel alpha7 nAchR agonists

Three related series of chemokine CCR5 modulators reported by GSK

Protective effects of pexelizumab in AMI patients

Avasimibe prevents plaque progression in patients with coronary atherosclerosis

Good safety profile of CVT-3146 in myocardial perfusion imaging

ED-71 increases bone formation and reduces bone resorption after bone marrow ablation in mice

TP-508 promotes fracture healing in rats via enhancement of immune responses

Antisense GHR inhibitor shows promise in animal studies

Crucell and NeoTropiX enter PER.C6 technology licensing agreement

Cypher sirolimus-eluting stent one step away from Japanese approval

Raptiva receives Swiss approval

Enrollment completed in phase III traumatic brain injury study of dexanabinol

Novo Nordisk obtains North American rights to IL-20

Panacos studies HIV maturation inhibitor in phase I trial

A-HeFT trial of BiDil cleared to continue by DSMB

Zydus Cadila launches Nucoxia in India

FGF-18 promotes cartilage repair in a rat model of injury-induced osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...